Live Breaking News & Updates on Merrimack Pharmaceuticals Trading Down

Stay updated with breaking news from Merrimack pharmaceuticals trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Merrimack Pharmaceuticals (NASDAQ:MACK) Shares Pass Above 200-Day Moving Average of $12.55

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $12.55 and traded as high as $13.47. Merrimack Pharmaceuticals shares last traded at $13.44, with a volume of 29,917 shares traded. Analysts Set New Price Targets Separately, StockNews.com […] ....

United States , United Kingdom , Eric Andersen , Merrimack Pharmaceuticals Trading Down , News Ratings For Merrimack Pharmaceuticals Daily , Merrimack Pharmaceuticals Inc , Securities Exchange Commission , Merrimack Pharmaceuticals , Citigroup Inc , Get Free Report , Pharmaceuticals Trading Down , Director Eric Andersen , Exchange Commission , California State Teachers Retirement System , Merrimack Pharmaceuticals Daily , Nasdaq Mack ,